The document discusses improving access to essential medicines and identifies several problems. It notes that two billion people lack access to essential medicines, and there is a large price variation for treatments between countries. Stockouts of essential medicines also occur when health facilities experience shortages. The document proposes several solutions, including greater use of generics, changing how innovation is rewarded, improving governance and transparency, and partnerships between different stakeholders.